86 related articles for article (PubMed ID: 14617836)
21. Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.
Egeli U; Cecener G; Tunca B; Tasdelen I
Cancer Invest; 2006; 24(5):484-91. PubMed ID: 16939956
[TBL] [Abstract][Full Text] [Related]
22. [Population genetic analysis of the association between the BRCA1 and P53 gene polymorphisms and the risk of sporadic breast cancer].
Tarasov VA; Aslanian MM; Tsyrendorzhieva ES; Gar'kavtseva RF; Liubchenko LN; Altukhov IuP; Mel'nik VA
Genetika; 2005 Aug; 41(8):1115-24. PubMed ID: 16161633
[TBL] [Abstract][Full Text] [Related]
23. Li-Fraumeni and Li-Fraumeni-like syndrome mutations in p53 are associated with exonic methylation and splicing regulatory elements.
Kouidou S; Malousi A; Maglaveras N
Mol Carcinog; 2009 Oct; 48(10):895-902. PubMed ID: 19367569
[TBL] [Abstract][Full Text] [Related]
24. Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin.
Preisler-Adams S; Schönbuchner I; Fiebig B; Welling B; Dworniczak B; Weber BH
Cancer Genet Cytogenet; 2006 Jul; 168(1):44-9. PubMed ID: 16772120
[TBL] [Abstract][Full Text] [Related]
25. [Genetics and cancer of the breast].
Sobol H; Bignon YJ; Eisinger F; Birnbaum D; Fervers B
Ann Chir; 1994; 48(4):303-8. PubMed ID: 8085754
[TBL] [Abstract][Full Text] [Related]
26. The spectrum and incidence of BRCA1 pathogenic mutations in Slovak breast/ovarian cancer families.
Konecny M; Vizvaryova M; Weismanova E; Ilencikova D; Mlkva I; Weismann P; Machackova G; Kausitz J
Neoplasma; 2007; 54(2):137-42. PubMed ID: 17319787
[TBL] [Abstract][Full Text] [Related]
27. Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks.
Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Edler L; Lubiński J; Scott RJ; Hamann U
Breast Cancer Res Treat; 2007 Sep; 104(3):299-308. PubMed ID: 17063264
[TBL] [Abstract][Full Text] [Related]
28. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
Cierniková S; Tomka M; Kovác M; Stevurková V; Zajac V
Neoplasma; 2006; 53(2):97-102. PubMed ID: 16575464
[TBL] [Abstract][Full Text] [Related]
29. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis.
Shen J; Ambrosone CB; DiCioccio RA; Odunsi K; Lele SB; Zhao H
Carcinogenesis; 2008 Oct; 29(10):1963-6. PubMed ID: 18660546
[TBL] [Abstract][Full Text] [Related]
30. [Mutational analysis of breast/ovarian cancer hereditary predisposition gene BRCA1 in Tunisian women].
Mestiri S; Monastiri K; Ben Ahmed S; Bouaouina N; Presneau N; Bignon YJ; Khairi H; Chouchane L
Arch Inst Pasteur Tunis; 2000; 77(1-4):11-5. PubMed ID: 14658222
[TBL] [Abstract][Full Text] [Related]
31. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA
Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457
[TBL] [Abstract][Full Text] [Related]
32. p53 genotypes and haplotypes associated with risk of breast cancer.
Buyru N; Altinisik J; Demokan S; Dalay N
Cancer Detect Prev; 2007; 31(3):207-13. PubMed ID: 17574348
[TBL] [Abstract][Full Text] [Related]
33. BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.
Ratajska M; Brozek I; Senkus-Konefka E; Jassem J; Stepnowska M; Palomba G; Pisano M; Casula M; Palmieri G; Borg A; Limon J
Oncol Rep; 2008 Jan; 19(1):263-8. PubMed ID: 18097605
[TBL] [Abstract][Full Text] [Related]
34. Germ line BAX alterations are infrequent in Li-Fraumeni syndrome.
Barlow JW; Mous M; Wiley JC; Varley JM; Lozano G; Strong LC; Malkin D
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1403-6. PubMed ID: 15298965
[TBL] [Abstract][Full Text] [Related]
35. Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age.
Trkova M; Prochazkova K; Krutilkova V; Sumerauer D; Sedlacek Z
Cancer; 2007 Aug; 110(3):694-702. PubMed ID: 17567834
[TBL] [Abstract][Full Text] [Related]
36. G:C > A:T mutations and potential epigenetic regulation of p53 in breast cancer.
Kouidou S; Malousi A; Kyventidis A; Fragou A; Maglaveras N
Breast Cancer Res Treat; 2007 Dec; 106(3):351-60. PubMed ID: 17505880
[TBL] [Abstract][Full Text] [Related]
37. Germline NBS1 mutations in families with aggregation of Breast and/or ovarian cancer from north-east Poland.
Kanka C; Brozek I; Skalska B; Siemiatkowska A; Limon J
Anticancer Res; 2007; 27(4C):3015-8. PubMed ID: 17695489
[TBL] [Abstract][Full Text] [Related]
38. Inherited predisposition to cancer: a historical overview.
Lynch HT; Shaw TG; Lynch JF
Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):5-22. PubMed ID: 15264268
[TBL] [Abstract][Full Text] [Related]
39. Identification of a common polymorphism in the TopBP1 gene associated with hereditary susceptibility to breast and ovarian cancer.
Karppinen SM; Erkko H; Reini K; Pospiech H; Heikkinen K; Rapakko K; Syväoja JE; Winqvist R
Eur J Cancer; 2006 Oct; 42(15):2647-52. PubMed ID: 16930991
[TBL] [Abstract][Full Text] [Related]
40. The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers.
Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Edler L; Lubiñski J; Scott RJ; Hamann U
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):270-5. PubMed ID: 17301259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
